SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.
Yuan L, Wu X, Zhang L, Yang M, Wang X, Huang W, Pan H, Wu Y, Huang J, Liang W, et al. Cancer Immunol Immunother. 2022 Feb; 71(2):399-415. Epub 2021 Jun 28.